Fermentative Production of Engineered Cationic Antimicrobial Peptide from Economically Feasible Bacterial Host E. coli GJ1158

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Bio-Science and Bio-Technology

• Publication date

  2013-10-31

• Fields of study

  Chemistry, Engineering, Environmental Science

• Identifiers
  DOI 10.14257/IJBSBT.2013.5.5.22
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Continuous Cellulosic Bioethanol Fermentation by Cyclic Fed-Batch Cocultivation

  2012cited by this paper
• Introduction to current and future protein therapeutics: a protein engineering perspective.

  2011cited by this paper
• High-Level Expression and Novel Antifungal Activity of Mouse Beta Defensin-1 Mature Peptide in Escherichia coli

  2010influential reference
• High-Level Expression of the Antimicrobial Peptide Plectasin in Escherichia coli

  2010cited by this paper
• Expression and purification of two different antimicrobial peptides, PR-39 and Protegrin-1 in Escherichia coli.

  2010cited by this paper
• Pilot-scale production and purification of a staphylokinase-based fusion protein over-expressed in Escherichia coli

  2009cited by this paper
• Expression and purification the antimicrobial peptide CM4 in Escherichia coli

  2009influential reference
• Nutrient Supplementation Strategies for Biopharmaceutical Production, Part 2 Feeding for Optimal Recombinant Protein Production

  2009cited by this paper
• High-Level Expression and Novel Purification Strategy of Recombinant Thanatin Analog in Escherichia coli

  2008cited by this paper
• Production of bioactive human beta-defensin 5 and 6 in Escherichia coli by soluble fusion expression.

  2008cited by this paper
• Hydrophobic interaction expanded bed adsorption chromatography (HI-EBAC) based facile purification of recombinant streptokinase from E. coli inclusion bodies.

  2007cited by this paper
• High-level production of bioactive human beta-defensin-4 in Escherichia coli by soluble fusion expression

  2006cited by this paper
• Expression of the cationic antimicrobial peptide lactoferricin fused with the anionic peptide in Escherichia coli

  2006cited by this paper
• Improving on nature's defenses: optimization & high throughput screening of antimicrobial peptides.

  2005cited by this paper
• A novel carrier molecule for high-level expression of peptide antibiotics in Escherichia coli.

  2004cited by this paper
• Expression and purification of a recombinant buforin derivative from Escherichia coli

  2004cited by this paper
• High-level expression and purification of a recombinant hBD-1 fused to LMM protein in Escherichia coli.

  2004cited by this paper
• Limiting factors in Escherichia coli fed-batch production of recombinant proteins.

  2003cited by this paper
• Effect of oxygen transfer on glycerol biosynthesis by an osmophilic yeast Candida magnoliae I(2)B.

  2002cited by this paper
• Optimization of staphylokinase production inBacillus subtilis using inducible and constitutive promoters

  2001cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Two useful dimensionless parameters that combine physiological, operational and bioreactor design parameters for improved control of dissolved oxygen

  2001cited by this paper
• A simple method for the purification of an antimicrobial peptide in recombinant Escherichia coli

  2001cited by this paper
• Effect of Oscillating Dissolved Oxygen Tension on the Production of Alginate by Azotobactervinelandii

  2001cited by this paper
• High-level expression of antimicrobial peptide mediated by a fusion partner reinforcing formation of inclusion bodies.

  2000cited by this paper
• Diversity of antimicrobial peptides and their mechanisms of action.

  1999cited by this paper
• Effect of specific production rate of recombinant protein on multimerization of plasmid vector and gene expression level.

  1999cited by this paper
• Production of Active Chimeric Pediocin AcH inEscherichia coli in the Absence of Processing and Secretion Genes from the Pediococcus pap Operon

  1998cited by this paper
• Determinants of recombinant production of antimicrobial cationic peptides and creation of peptide variants in bacteria.

  1998cited by this paper
• Crystal structure of the catalytic domain of human plasmin complexed with streptokinase.

  1998cited by this paper
• Enhanced Production of Human Mini‐Proinsulin in Fed‐Batch Cultures at High Cell Density of Escherichia coli BL21(DE3) [pET‐3aT2M2]

  1997cited by this paper
• Improvement in recombinant protein production in ppGpp-deficient Escherichia coli.

  1997cited by this paper
• High cell-density culture of Escherichia coli.

  1996cited by this paper
• Characteristics and Performance of an Autotuning Proportional Integral Derivative Controller for Dissolved Oxygen Concentration

  1994cited by this paper
• Biologically active and amidated cecropin produced in a baculovirus expression system from a fusion construct containing the antibody-binding part of protein A.

  1991cited by this paper
• The production of recombinant beta-galactosidase inEscherichia coli in yeast extract enriched medium

  1990cited by this paper
• Effects of fermentation feeding strategies prior to induction of expression of a recombinant malaria antigen inEscherichia coli

  1987cited by this paper
• Factors influencing productivity of fermentations employing recombinant microorganisms

  1986cited by this paper

• Molecular Cloning, High Level Expression and Activity Analysis of Constructed Human Interleukin–25 Using Industrially Important IPTG Inducible Escherichia coli BL21(DE3)

  2014cites this paper
• Cloning and High Level Production of Engineered Synthetic Cationic Antimicrobial Peptide using Methanol Inducible Pichia pastoris GS115

  2014cites this paper